Glucocorticoid hormone programming in early-life and its impact on adult health

References

• Barker DJP. The developmental origins of well-being. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 359 (1449), 1359–1366 (2004).
   PubMed Web of Science ®Google Scholar
• Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 341, 938–941 (1993).
   PubMed Web of Science ®Google Scholar
• Edwards CRW, Benediktsson R, Lindsay R, Seckl JR. Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension? Lancet 341, 355–357 (1993).
   PubMed Web of Science ®Google Scholar
• Gluckman P, Hanson M. Living with the past: evolution, development, and patterns of disease. Science 305, 1733–1736 (2004).
   PubMed Web of Science ®Google Scholar
• Beitens IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr. Res. 7, 509–519 (1973).
   PubMedGoogle Scholar
• Benediktsson R, Calder AA, Edwards CRW, Seckl JR. Placental 11β-hydroxysteroid dehydrogenase Type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin. Endocrinol. 46, 161–166 (1997).
   PubMed Web of Science ®Google Scholar
• Stewart PM, Rogerson FM, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab. 80, 885–890 (1995).
   PubMed Web of Science ®Google Scholar
• Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW. Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet 341, 339–341 (1993).
   PubMed Web of Science ®Google Scholar
• Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR. Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27, 1200–1204 (1996).
   PubMed Web of Science ®Google Scholar
• Langley-Evans SC, Philips G, Benediktsson R et al. Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 17, 169–172 (1996).
   Google Scholar
• Dodic M, May CN, Wintour EM, Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. 94, 149–155 (1998).
   PubMed Web of Science ®Google Scholar
• Seckl J. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 151, U49–U62 (2004).
   PubMed Web of Science ®Google Scholar
• Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101, 2174–2181 (1998).
   PubMed Web of Science ®Google Scholar
• Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JR, Newnham JP. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am. J. Physiol.281(3), R960–R970 (2001).
   Web of Science ®Google Scholar
• Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am. J. Physiol. 288, R34–R38 (2005).
   PubMed Web of Science ®Google Scholar
• Blondeau B, Lesage J, Czernichow P, Dupouy JP, Breant B. Glucocorticoids impair fetal β-cell development in rats. Am. J. Physiol. 281(3), E592–E599 (2001).
   PubMed Web of Science ®Google Scholar
• Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet. Gynecol. 94(2), 213–218 (1999).
   PubMed Web of Science ®Google Scholar
• Matthews SG. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol. Metab. 130, 373–380 (2002).
   Google Scholar
• Welberg LAM, Seckl JR, Holmes MC. Inhibition of 11β-hydroxysteroid dehydrogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the offspring. Eur. J. Neurosci. 12, 1047–1054 (2000).
   PubMed Web of Science ®Google Scholar
• Welberg LAM, Seckl JR, Holmes MC. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behavior. Neuroscience 104, 71–79 (2001).
   PubMed Web of Science ®Google Scholar
• Weaver I, Cervoni N, Champagne F et al. Epigenetic programming by maternal behavior. Nature Neurosci. 7, 847–854 (2004).
   PubMed Web of Science ®Google Scholar
• Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20, 439–449 (1995).
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci. 98, 137–142 (2000).
   Web of Science ®Google Scholar
• Dalziel SR, Walker NK, Parag V. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365(9474), 1856–1862 (2005).
   PubMed Web of Science ®Google Scholar
• Vickers MH, Gluckman PD, Coveny AH et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 146(10), 4211–4216 (2005).
   PubMed Web of Science ®Google Scholar
• Cleasby ME, Livingstone DEW, Nyirenda MJ, Seckl JR, Walker BR. Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? Eur. J. Endocrinol.. 148(1), 129–138 (2003).
   Google Scholar